LauraMauriMD
Cardiology • Boston, MAAdult Congenital Heart Disease, Heart Failure & Transplantation, Interventional Cardiology
Associate Professor of Medicine, Brigham and Women's Hospital
Are you Dr. Mauri?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 58 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1620 Tremont St
Brighams and Womens Hospital Div of Clinical Biometrics
Boston, MA 02120Phone+1 617-732-8936Fax+1 617-525-8027
Summary
- Dr. Laura Mauri, MD is a cardiologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is an Associate Professor of Medicine at Brigham and Women's Hospital.
Education & Training
Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1999 - 2002
Harvard Medical SchoolClass of 1996
Certifications & Licensure
MA State Medical License 1998 - 2025
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Randomized Study Comparing Endeavor With Cypher Stents (PROTECT) Start of enrollment: 2007 Jun 01
- The Medtronic RESOLUTE US Clinical Trial Start of enrollment: 2008 Jul 01
- PERVIDEO I Registry, The Lutonix Paclitaxel-Coated Balloon Catheter for the Treatment of Coronary In-Stent Restenosis Start of enrollment: 2009 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 564 citations2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTSMarco Valgimigli, Héctor Bueno, Robert A. Byrne, Jean-Philippe Collet, Francesco Costa
European Journal of Cardio-Thoracic Surgery. 2018-01-01 - 14 citationsMyocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy).Ada C. Stefanescu Schmidt, Dean J. Kereiakes, Donald E. Cutlip, Robert W. Yeh, Ralph B. D'Agostino
Circulation. 2017-05-02 - 2049 citations2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular DiseaseDonna K. Arnett, Roger S. Blumenthal, Michelle A. Albert, Erin D. Michos, Andrew B. Buroker
Journal of the American College of Cardiology. 2019-03-17
Authored Content
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsMarch 2017
Press Mentions
Representation Matters in Clinical TrialsFebruary 13th, 2023- Positive Airway Pressure Devices Market Report- Top Manufacturers and Future Growth | Airing LLC, Beijing Dehaier Medical Technology Co LtdMay 11th, 2021
- 2020 MIS Devices Market Report- Size, Business Opportunities, Segmentation and Regional OverviewSeptember 19th, 2020
- Join now to see all
Professional Memberships
- Member
